What is the recommended workup for a 49-year-old patient on psychiatric medications, including lithium, valproate, or selective serotonin reuptake inhibitors (SSRIs), who presents with a new onset of tremor?

Workup for New Tremor in a 49-Year-Old on Psychiatric Medications

The workup should focus on identifying medication-induced tremor as the primary etiology, followed by exclusion of metabolic causes and structural neurological disease, with the understanding that psychiatric medications—particularly lithium, valproate, and SSRIs—are among the most common tremorogenic drugs. 1, 2

Initial Clinical Assessment

Medication Review (First Priority)

• Identify all current psychiatric medications and their doses, as lithium, valproate, SSRIs/SNRIs, and antipsychotics are the most common tremor-inducing drugs in psychiatric patients 1, 2, 3
• Document timing of tremor onset relative to medication initiation, dose changes, or addition of new agents 1
• Assess for polypharmacy, which is a significant risk factor for drug-induced tremor 1
• Review for immediate-release preparations versus extended-release formulations, as immediate-release forms increase tremor risk 1

Tremor Characterization

• Determine if the tremor is postural (most common in drug-induced tremor), resting (suggests parkinsonism), or kinetic 2, 3
• Assess whether tremor is bilateral and symmetric (typical of drug-induced) versus unilateral or asymmetric (suggests alternative etiology) 1
• Evaluate for sudden onset, distractibility, entrainment, or arrest with contralateral movements, which would suggest functional tremor rather than drug-induced 1
• Document body parts affected—arms are most commonly involved in essential and drug-induced tremor 4

Laboratory Workup

Essential Screening Tests

• Lithium level (if patient is on lithium)—tremor can occur at therapeutic levels but worsens with toxicity 2, 3
• Valproate level (if patient is on valproate)—toxic levels increase tremor risk 1, 2
• Thyroid function tests (TSH, free T4)—both hypothyroidism and hyperthyroidism can cause tremor 5
• Basic metabolic panel—to assess renal function (affects lithium clearance) and electrolytes 5
• Complete blood count—though low yield as a routine test, it may identify anemia or infection in select cases 5

Selective Additional Testing

• Liver function tests if on valproate or other hepatically metabolized medications 5
• Calcium and magnesium levels if clinical suspicion for metabolic derangement exists 5
• Urine drug screen if substance use (cocaine, amphetamines) is suspected, as these can cause tremor 1, 3

The evidence shows that routine laboratory testing in psychiatric patients has very low yield (1.4-1.8% clinically meaningful results) when not guided by history and physical examination 5. Therefore, avoid shotgun laboratory approaches and order tests based on specific clinical indicators.

Neuroimaging Considerations

• Brain MRI is NOT routinely indicated for isolated tremor in a patient on known tremorogenic medications 5
• Consider MRI only if there are focal neurological signs, asymmetric tremor, rapid progression, or features suggesting structural disease 5
• The vast majority of clinically significant findings can be predicted from careful history and examination alone 5

Risk Factors to Document

• Male gender, older age, and high medication doses are established risk factors for drug-induced tremor 1
• Assess for concurrent use of other tremorogenic substances including caffeine and beta-agonists 3
• Document any family history of essential tremor, which may lower the threshold for medication-induced tremor 4

Common Pitfalls to Avoid

• Do not assume tremor is benign essential tremor without first excluding medication causes—this is the most common diagnostic error 1, 3
• Do not order extensive neuroimaging or specialized testing before addressing medication review and basic metabolic screening 5
• Recognize that drug-induced tremor usually resembles essential tremor (postural) or parkinsonian tremor depending on the offending agent 1
• Be aware that tremor may persist even after medication discontinuation (tardive tremor), though most cases resolve 1

Management Implications of Workup

Once drug-induced tremor is confirmed and metabolic causes excluded:

• The primary intervention is dose reduction or discontinuation of the offending agent 1, 2, 3
• If medication cannot be discontinued, consider switching to an alternative with lower tremor risk 2
• Pharmacological treatment with propranolol or primidone may be considered for persistent disabling tremor 2, 4, 6